10,742
Participants
Start Date
October 18, 2024
Primary Completion Date
January 1, 2029
Study Completion Date
February 1, 2030
Aspirin 81 mg
Participants will be assigned to 81mg Aspirin
Aspirin 162 mg
Participants will be assigned to 162mg Aspirin
RECRUITING
Columbia University, New York
RECRUITING
University of Pittsburg Magee, Pittsburgh
RECRUITING
Eastern Virginia Medical School - Old Dominion University, Norfolk
RECRUITING
University of North Carolina, Chapel Hill, Chapel Hill
RECRUITING
University of New Mexico, Albuquerque
RECRUITING
University of Mississippi, Jackson
RECRUITING
The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine, Columbus
RECRUITING
Northwestern University, Chicago
RECRUITING
University of Texas, Houston, Houston
RECRUITING
Cedars Sinai Medical Center, Los Angeles
RECRUITING
University of California, San Francisco, San Francisco
RECRUITING
Brown University, Providence
Patient-Centered Outcomes Research Institute
OTHER
Northwestern University
OTHER
Preeclampsia Foundation
OTHER
Ohio State University
OTHER